Search results
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks· 4 days agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's disease. This marks the second sBLA filing for Tremfya in three months.
Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN) Shares Cross Below 200-Day Moving Average of...
ETF DAILY NEWS· 3 days agoShares of Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of ...
How to invest $1 million: 4 strategies
CNN.com· 7 days ago“My family personally lost more than a million dollars when I was a child, leaving us destitute and leading me to pursue a career as a certified...
Asus Zenscreen MB249C portable monitor review
TechRadar· 4 days agoA portable monitor that misses the mark